abstract
unrecogn
viru
novel
coronaviru
design
sarsassoci
coronaviru
sarscov
novemb
juli
cumul
number
worldwid
case
mortal
rate
close
mortal
higher
older
patient
comorbid
sar
defin
use
clinic
epidemiolog
criteria
case
consid
laboratoryconfirm
sar
coronaviru
isol
antibodi
sar
coronaviru
detect
polymeras
chain
reaction
test
appropri
criteria
posit
time
write
may
specif
therapi
recommend
varieti
treatment
attempt
control
data
patient
treat
throughout
ill
broadspectrum
antimicrobi
supplement
oxygen
intraven
fluid
support
measur
transmiss
sar
facilit
close
contact
patient
symptomat
infect
major
case
report
among
healthcar
provid
famili
member
sar
patient
sinc
sarscov
contagi
measur
prevent
center
avoid
exposur
infect
control
strategi
suspect
case
contact
includ
standard
precaut
hand
hygien
contact
precaut
gown
goggl
glove
airborn
precaut
neg
pressur
room
high
effici
mask
light
report
new
case
identifi
winter
china
seem
possibl
sar
import
caus
pneumonia
futur
screen
outpati
risk
sar
may
becom
part
pneumonia
evalu
sever
acut
respiratori
syndrom
sar
first
definit
nize
guangdong
provinc
southeast
china
late
surveil
purpos
avail
laboraand
subsequ
spread
global
rapidli
earli
tori
test
detect
caus
agent
sar
origin
month
sar
captur
worldwid
attent
defin
use
clinic
epidemiolog
criteria
suspect
highli
infecti
diseas
high
mortal
occupationprob
case
suspect
case
includ
respiratori
ill
al
hazard
among
healthcar
provid
impact
sar
unknown
etiolog
follow
criteria
extens
sociolog
econom
consequ
measur
temperatur
particularli
asia
caus
agent
sar
one
clinic
find
respiratori
ill
eg
cough
contagi
prevent
measur
focu
avoid
exposhort
breath
difficulti
breath
hypoxia
sure
infect
control
strategi
suspect
patient
travel
within
day
onset
symptom
area
contact
emerg
sar
illustr
need
global
suspect
document
commun
transmiss
sar
cooper
healthcar
system
ensur
public
health
exclud
area
secondari
case
limit
healthcar
local
region
need
prepar
rapidli
institut
worker
direct
household
contact
close
contact
within
polici
respond
newli
emerg
infecti
threat
day
onset
symptom
either
person
respiratori
ill
person
investig
suspect
recombin
event
mammalianlik
avianlik
parof
sar
ent
virus
may
respons
switch
host
sarscov
anim
human
probabl
case
defin
suspect
case
either
radiograph
evid
pneumonia
respiratori
distress
syndrom
autopsi
find
consist
respiratori
distress
epidemiolog
syndrom
without
identifi
caus
viru
identifi
laboratori
test
becam
juli
cumul
number
worldwid
sar
avail
detect
surveil
case
definit
sar
case
mortal
report
case
updat
includ
laboratori
criteria
evid
infect
china
hong
kong
taiwan
sarsassoci
coronaviru
sarscov
initi
canada
singapor
us
sinc
unclear
whether
sar
infect
could
present
rel
spare
clinic
impact
sar
juli
peopl
asymptomat
definit
includ
probabl
case
report
eight
biliti
asymptomat
subclin
infect
howev
subselaboratori
confirm
acut
coronaviru
infect
quent
investig
suggest
asymptomat
infect
initi
case
report
hong
kong
link
index
uncommon
consequ
latest
surveil
case
defipati
medic
doctor
guangdong
provinc
china
nition
sar
us
center
diseas
control
travel
hong
kong
attend
wed
late
februari
prevent
cdc
updat
includ
clinic
criteria
previous
treat
patient
atyp
pneuearli
ill
mildtomoder
ill
sever
respiratori
illmonia
guangdong
subsequ
sever
guest
stay
ness
character
epidemiolog
laboraat
hotel
becam
ill
sar
patient
subsetori
criteria
tabl
quentli
infect
numer
healthcar
worker
famili
member
becam
index
case
countri
canada
vietnam
singapor
etc
figur
mortal
higher
older
patient
comorbid
syndrom
observ
primarili
soon
recognit
clinic
syndrom
sar
adult
age
year
children
rel
spare
sever
differ
laboratori
identifi
novel
coronaviru
desigther
appear
signific
underli
predispos
condin
sarscov
vero
cell
cultur
inocul
respirt
develop
sar
howev
elderli
atori
secret
lung
tissu
infect
patient
patient
underli
condit
greater
risk
mortalitechniqu
includ
electron
microscopi
revers
transcriptionti
one
studi
hong
kong
mortal
year
polymeras
chain
reaction
rtpcr
serovonvers
age
anoth
studi
multivari
analysi
show
also
point
caus
agent
seroepidemiolog
age
year
presenc
diabet
mellitu
heart
diseas
data
indic
sarscov
previous
found
presenc
comorbid
condit
independenthuman
preliminari
report
detect
sar
ly
associ
mortal
earli
evalu
coronaviru
himalayan
palm
civet
cat
number
syndrom
descript
patient
requir
speci
suggest
interspeci
transmiss
new
hospit
howev
case
identifi
particuviru
investig
hong
kong
report
coronaviru
relarli
western
countri
major
patient
sembl
sar
viru
isol
sever
himalayan
palm
civet
requir
hospit
cat
raccoon
dog
obtain
market
guangdong
provinc
anim
consid
food
delicaci
sar
appear
transmit
close
contact
patient
region
also
report
sever
handler
ill
due
sar
viru
greatest
risk
market
antibodi
sar
viru
studi
genet
transmiss
probabl
via
direct
contact
respiratori
sequenc
two
virus
show
similar
pattern
suggest
secret
evid
spread
patient
speci
jump
wild
anim
human
furthermor
experithey
develop
symptom
major
case
report
mental
infect
macaqu
sarscov
produc
pneuamong
healthcar
worker
famili
member
affect
permonia
patholog
similar
sar
human
son
howev
evid
commun
spread
diseas
stavrinid
guttman
compar
sarscov
genom
emerg
suggest
mode
transmiss
relat
coronavirus
found
half
dna
resembl
airborn
direct
contact
may
also
role
cluster
case
coronaviru
sequenc
mammal
half
look
commun
set
hotel
apart
build
like
viru
found
bird
data
suggest
possibl
past
demonstr
transmiss
effici
mani
household
clinic
criteria
presenc
two
follow
featur
fever
might
subject
chill
rigor
myalgia
headach
diarrhea
sore
throat
rhinorrhea
temperatur
one
clinic
find
lower
respiratori
ill
eg
cough
short
breath
difficulti
breath
meet
clinic
criteria
mildtomoder
respiratori
ill
one
follow
find
radiograph
evid
pneumonia
acut
respiratori
distress
syndrom
autopsi
find
consist
pneumonia
acut
respiratori
distress
syndrom
without
identifi
caus
one
follow
exposur
day
onset
symptom
travel
foreign
domest
locat
document
suspect
recent
transmiss
sarscov
close
contact
person
mildtomoder
sever
respiratori
ill
histori
travel
day
onset
symptom
foreign
domest
locat
document
suspect
recent
transmiss
sarscov
one
follow
exposur
day
onset
symptom
close
contact
person
confirm
sarscov
diseas
close
contact
person
mildtomoder
sever
respiratori
ill
chain
transmiss
link
confirm
case
sarscov
diseas
day
onset
symptom
detect
serum
antibodi
sarscov
test
valid
cdc
eg
enzym
immunoassay
isol
cell
cultur
sarscov
clinic
specimen
detect
sarscov
rna
rtpcr
test
valid
cdc
subsequ
confirm
refer
laboratori
eg
cdc
case
classif
b
probabl
case
sarscov
diseas
meet
clinic
criteria
sever
respiratori
ill
epidemiolog
criteria
like
exposur
sarscov
confirm
case
sarscov
diseas
clinic
compat
ill
ie
earli
mildtomoder
sever
laboratori
confirm
test
detect
sarscov
refin
therefor
criteria
laboratori
diagnosi
sarscov
chang
b
asymptomat
infect
clinic
manifest
respiratori
ill
may
identifi
futur
learn
sarscov
cdc
center
diseas
control
rtpcr
revers
transcript
polymeras
chain
reaction
sarscov
sarsassoci
coronaviru
contact
becom
ill
epidemiolog
evid
indic
quir
sar
via
contact
fomit
still
unexplain
signific
patient
involv
transmiss
transmiss
sar
facilit
facetofac
contact
unusu
larg
number
secondari
case
socal
superand
still
appear
common
mode
spread
spread
event
form
droplet
transmiss
howev
airborn
fecal
transmiss
may
role
set
could
account
peiri
et
al
studi
viral
load
sarscov
time
extens
spread
within
build
confin
area
respiratori
secret
sar
patient
found
load
observ
place
asia
transmiss
via
casual
nasopharyng
aspir
increas
peak
tenth
day
contact
uncommon
document
airplan
onset
symptom
decreas
gradual
notwithstand
taxi
healthcar
worker
also
appear
acsmal
sampl
size
effect
concomit
administr
ribavirin
corticosteroid
suggest
sar
patient
virolog
beij
viru
appar
transmit
student
mother
nurs
care
student
three
might
contagi
second
week
ill
laboratoryconfirm
case
time
write
total
nine
termin
initi
outbreak
sar
juli
possibl
case
sar
identifi
health
two
case
sarscov
infect
iti
involv
activ
surveil
identifi
possibl
like
acquir
laboratori
set
one
case
late
august
case
decemb
reinforc
necess
care
laboratori
practic
work
viru
clinic
manifest
appear
evid
secondari
transmiss
associ
either
case
despit
activ
social
activ
undertaken
initi
descript
clinic
manifest
sar
two
scientist
exposur
sarscov
come
report
patient
requir
hospitalizaaddit
four
communityacquir
case
guangdong
tion
patient
diseas
often
report
biprovinc
china
subsequ
diagnos
decemb
phasic
triphas
ill
initi
acut
febril
phase
januari
interest
close
contact
follow
lower
respiratori
ill
phase
progress
case
found
fever
respiratori
symptom
home
approxim
patient
phase
character
quarantin
date
recent
april
chines
acut
respiratori
distress
syndrom
ard
necessit
ventil
support
ministri
health
report
addit
case
sar
seem
initi
associ
index
case
imper
appreci
individu
patient
old
femal
graduat
student
work
nation
institut
necessarili
display
phase
could
highli
individ
peiri
et
al
n
lee
et
al
n
poutanen
et
al
n
tsang
et
al
n
ualiz
hyperacut
indol
present
time
cours
festat
patient
describ
figur
although
time
write
mortal
probabl
sar
case
major
patient
develop
symptom
respiratori
tract
inapproxim
much
higher
older
individu
fection
admiss
minor
patient
sympthos
signific
comorbid
tom
time
admiss
hospit
diarrhea
present
mean
incub
period
sar
estim
day
time
admiss
develop
usual
rang
approxim
day
exposymptom
hospit
investig
also
observ
sure
ill
gener
begin
prodrom
fever
durat
time
onset
ill
evolut
often
associ
chill
rigor
myalgia
headach
variou
endpoint
diseas
fever
day
admiss
sever
malais
may
accompani
phase
rash
absent
case
one
outbreak
within
apart
complex
hong
kong
diarrhea
found
case
typic
period
day
lower
respiratori
phase
may
begin
onset
nonproduct
cough
progress
pneumonia
initi
report
case
patient
requir
intens
care
unit
manag
mechan
ventil
present
symptom
patient
admit
hospit
four
publish
seri
list
tabl
ii
patient
admit
hospit
sever
day
onset
symptom
common
complaint
fever
chill
rigor
upper
respiratori
tract
symptom
rhinorrhea
sore
throat
less
common
time
examin
abnorm
auscultatori
find
present
onethird
patient
although
fever
progress
respiratori
manifest
hallmark
case
sar
patient
indol
characterist
includ
absenc
fever
describedespeci
elderli
immunocompromis
patient
first
report
complet
outbreak
sar
begin
outbreak
declar
contain
recent
publish
vu
et
al
report
cohort
patient
requir
hospit
present
similar
mani
hospit
day
onset
radiograph
chang
day
onset
multivari
analysi
factor
predict
respiratori
symptom
day
onset
maxim
radiograph
advers
outcom
advanc
age
high
peak
lactat
chang
day
onset
intub
day
onset
end
dehydrogenas
level
higher
absolut
neutrophil
count
fever
day
onset
death
day
diagnosi
chest
xray
abnorm
usual
absent
initi
phase
ill
becom
progress
abnorm
initi
manifest
sar
specif
phase
lower
respiratori
ill
initi
character
easili
distinguish
respiratori
infect
earli
focal
interstiti
infiltr
usual
seen
ground
glass
first
clinic
definit
develop
see
section
opac
progress
bilater
diseas
figur
typic
found
sensit
approxim
ard
pictur
emerg
mani
serious
ill
patient
specif
identifi
laboratori
document
case
clinician
patient
highresolut
comput
tomographi
hrct
conduct
thorough
diagnost
test
rule
etiolomor
sensit
earli
diseas
chest
xray
could
gie
patient
suspect
sar
initi
recommend
normal
show
inconclus
consolid
characteristidiagnost
test
procedur
includ
chest
radiograph
puls
calli
hrct
show
peripher
commonli
lower
lobe
oximetri
sinc
sar
often
progress
rapidli
repeat
chest
xconsolid
although
nondiagnost
close
mimickray
within
first
second
day
sometim
twice
daili
may
ing
appear
bronchiol
obliteran
organ
help
document
cours
diseas
indiscrimin
use
pneumonia
hrct
also
help
show
evid
hrct
detect
radiograph
occult
diseas
discourpleur
effus
intrathorac
lymphadenopathi
age
view
infect
control
issu
rapidli
progresrar
seen
sar
spontan
pneumomediastinum
sive
natur
sar
thu
make
like
radiograph
also
occur
rare
complic
sar
abnorm
would
appar
within
day
laboratori
abnorm
often
associ
sar
hospit
test
evalu
specif
organ
assoinclud
absolut
lymphopenia
mild
neutropenia
thromboci
pneumonia
perform
includ
blood
cytopenia
mild
moder
elev
plasma
level
creatin
cultur
sputum
gram
stain
cultur
test
viral
phosphokinas
lactat
dehydrogenas
transaminas
respiratori
pathogen
especi
influenza
respiratori
synseen
case
tabl
ii
cytial
viru
urinari
antigen
pneumococcu
spp
lee
et
al
found
advanc
age
male
sex
high
level
legionella
spp
also
consid
acut
convalesc
serum
creatin
phosphokinas
serum
lactat
dehydrogenas
serum
prefer
day
onset
symptom
rel
high
initi
neutrophil
count
ie
mean
vs
collect
patient
meet
sar
clinic
case
l
low
level
serum
sodium
signific
predicdefinit
howev
acut
convalesc
phase
sera
tive
factor
intens
care
unit
admiss
death
collect
least
day
apart
greater
rise
differ
rtpcr
assay
perform
differ
specimen
aliquot
identifi
coronaviru
rna
possibl
falseneg
cultur
rtpcr
assay
absenc
antibodi
serum
specimen
obtain
day
symptom
onset
consid
cdc
neg
laboratori
test
sar
coronaviru
likelihood
detect
sarscov
increas
multipl
specimen
eg
stool
serum
respiratori
tract
specimen
collect
cours
ill
clinician
consult
local
laboratori
personnel
health
depart
obtain
test
prioriti
specimen
sarscov
test
optim
time
collect
present
tabl
iii
patient
clinic
sar
describ
peiri
et
al
serolog
pcr
evid
sarsassoci
coronaviru
infect
unconfirm
serolog
test
prior
day
onset
ill
possibl
prior
time
seroconvers
anoth
seri
case
hong
kong
show
despit
significantli
high
dosag
corticosteroid
therapi
seroconvers
occur
day
onset
ill
differ
us
experi
probabl
case
sar
report
juli
confirm
laboratori
diagnosi
serolog
neg
result
b
antibodi
test
also
carri
serum
sampl
collect
day
symptom
onset
antibodi
titer
test
parallel
consid
indic
confirm
case
varieti
method
detect
coronaviru
infect
avail
includ
cultur
method
pcrbase
method
serolog
test
cultur
sar
coronaviru
consid
solid
evid
infect
problem
variou
gener
rtpcr
assay
falseposit
result
inconsist
detect
viral
genom
first
day
ill
well
later
convalesc
phase
therefor
recommend
detect
sarscov
rna
rtpcr
valid
second
refer
laboratori
antibodi
sar
coronaviru
found
gener
popul
background
sar
coronaviru
antibodi
appear
substanti
concern
howev
current
serolog
assay
elisa
ifa
indirect
fluoresc
antibodi
format
reliabl
detect
antibodi
titer
rise
substanti
second
week
ill
accord
uscdc
suspect
probabl
case
consid
laboratoryconfirm
sar
coronaviru
isol
antibodi
sar
coronaviru
detect
confirm
second
refer
laboratori
two
tabl
iv
summari
infect
control
precaut
patient
hospit
suspectedprob
sever
acut
respiratori
syndrom
sar
reproduc
sampathkumar
et
al
permiss
place
patient
neg
pressur
special
vent
room
number
agent
suggest
therapi
sarscov
includ
glycyrrhizin
proteas
inhibitor
one
preliminari
uncontrol
studi
loutfi
et
al
toronto
use
interferon
minimum
day
increas
total
day
plu
corticosteroid
oral
prednison
twice
day
intraven
methylprednisolon
everi
hour
associ
reduc
diseaseassoci
impair
oxygen
satur
rapid
resolut
radiograph
lung
abnorm
author
acknowledg
howev
find
need
interpret
cautious
view
lack
random
retrospect
dose
limit
sampl
size
total
patient
tabl
v
summari
protect
measur
taken
sever
acut
respiratori
syndrom
sar
infect
noninfect
staff
hong
kong
hospit
reproduc
seto
et
al
c
compar
proport
infect
n
noninfect
staff
n
without
mask
sinc
caus
agent
sar
contagi
absenc
effect
drug
vaccin
current
effect
strategi
treatment
limit
impact
sar
implement
prevent
time
write
may
specif
therapi
recommend
varieti
treatment
attempt
control
data
patient
treat
throughout
ill
broadspectrum
antimicrobi
supplement
oxygen
intraven
fluid
support
measur
clinician
advoc
combin
ribavirin
corticosteroid
efficaci
drug
establish
use
system
corticosteroid
sar
controversi
efficaci
base
control
studi
unavail
one
studi
found
initi
use
pulsedos
methyl
prednisolon
mgday
efficaci
equal
well
toler
lower
dose
methyl
prednisolon
base
retrospect
observ
evalu
use
corticosteroid
patient
viral
infect
hazard
accompani
effect
antivir
agent
earli
test
ribavirin
antivir
compound
novel
coronaviru
produc
evid
vitro
activ
evalu
use
ribavirin
publish
knowl
et
al
report
advers
event
patient
suspect
probabl
sar
treat
ribavirin
patient
evid
hemolyt
anemia
hypocalcemia
hypomagnesemia
detect
patient
respect
author
felt
benefit
ribavirin
may
outweigh
risk
advers
event
potenti
ribavirin
neg
clinic
econom
consequ
advers
event
consid
among
tabl
vi
recommend
evalu
patient
communityacquir
respiratori
ill
presenc
absenc
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
transmiss
world
absenc
sarscov
transmiss
anywher
world
diagnosi
sarscov
diseas
consid
patient
requir
hospit
radiograph
confirm
pneumonia
epidemiolog
histori
rais
suspicion
sarscov
diseas
absenc
sarscov
transmiss
anywher
world
suspicion
sar
infect
rais
within
day
symptom
onset
patient
histori
recent
travel
mainland
china
hong
kong
taiwan
close
contact
ill
peopl
histori
recent
travel
area
employ
occup
particular
risk
sarscov
exposur
includ
healthcar
worker
direct
contact
worker
laboratori
contain
live
sarscov
part
cluster
case
atyp
pneumonia
without
altern
diagnosi
sarscov
transmiss
document
world
diagnosi
sar
still
consid
patient
requir
hospit
pneumonia
epidemiolog
histori
describ
addit
patient
fever
respiratori
symptom
question
whether
within
day
symptom
onset
close
contact
someon
suspect
sarscov
diseas
histori
foreign
travel
close
contact
ill
person
histori
travel
locat
document
suspect
sarscov
infect
exposur
domest
locat
document
suspect
sarscov
includ
laboratori
contain
live
sarscov
close
contact
ill
person
exposur
histori
fig
algorithm
evalu
manag
patient
requir
hospit
radiograph
confirm
pneumonia
absenc
persontoperson
transmiss
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
anywher
world
measur
center
avoid
exposur
infect
hospit
patient
suspect
sar
isol
measur
includ
global
region
surveil
earli
detect
neg
pressur
room
healthcar
worker
wear
mask
new
case
identif
patient
contact
strict
adher
high
effici
mask
respir
use
enc
infect
control
polici
guidelin
infect
control
tuberculosi
prevent
airdroplet
airborn
acquisit
behav
publish
consult
updat
recomcaus
coronavirus
surviv
environment
surfac
good
mendat
healthcar
worker
encount
possibl
case
handwash
soap
water
use
alcoholbas
hand
sar
suspect
probabl
take
meticul
safeti
rub
highli
recommend
well
environment
surfac
precaut
seek
advic
expert
sar
infect
frequent
touch
patient
soil
bodi
fluid
control
clean
disinfect
household
disinfect
earli
symptom
sarscov
diseas
usual
includ
fever
chill
rigor
myalgia
headach
respiratori
symptom
often
appear
day
onset
ill
set
extens
transmiss
patient
fever
respiratori
symptom
evalu
possibl
sarscov
diseas
depend
symptom
exposur
histori
initi
diagnost
test
patient
may
includ
complet
blood
count
chest
xray
cxr
puls
oximetri
blood
cultur
sputum
gram
stain
cultur
test
viral
respiratori
pathogen
notabl
influenza
respiratori
syncyti
viru
legionella
sp
pneumococc
urinari
antigen
altern
diagnosi
base
laboratori
test
highpredict
valu
eg
blood
cultur
urinari
antigen
chest
comput
tomographi
ct
may
show
evid
inflitr
cxr
therefor
chest
ct
consid
patient
strong
epidemiolog
link
known
case
sar
neg
cxr
day
onset
symptom
sar
isol
precaut
discontinu
consult
local
public
health
author
evalu
physician
import
characterist
recent
sar
outbreak
infect
transmiss
tabl
iv
list
precaut
patient
hospit
sar
predilect
transmiss
healthcar
provid
patient
care
part
occur
close
patient
sarscov
diseas
otherwis
need
unprotect
contact
symptomat
individu
healthcar
hospit
manag
appropri
outpati
worker
unprotect
exposur
develop
patient
limit
interact
outsid
home
fever
respiratori
symptom
come
work
instruct
wear
surgic
mask
presenc
report
symptom
infect
controlemploye
household
contact
contain
respiratori
secret
facial
tissu
health
servic
physician
immedi
healthcar
workand
wash
hand
frequent
stay
away
work
er
unprotect
exposur
procedur
school
public
place
day
resolut
fever
high
risk
aerosol
eg
intub
bronchoscopi
household
member
close
contact
patient
wear
glove
practic
good
hand
hygien
abb
quarantin
period
sinc
high
risk
senc
fever
respiratori
symptom
need
limit
sar
polici
run
sinc
middl
march
queen
mari
hospit
univers
hong
kong
activ
despit
disappear
sar
hong
kong
sinc
june
import
sar
precaut
demonstr
author
minimum
number
staff
work
casecontrol
studi
five
hong
kong
hospit
nonthes
ward
may
enter
premis
staff
enter
infect
infect
healthcar
provid
documentrestrict
area
follow
strict
stepwis
gown
degown
contact
sar
patient
tabl
v
healthcar
ing
procedur
use
standard
person
protect
equip
provid
survey
concern
use
mask
glove
dispos
surgic
paper
cap
mask
reusabl
eye
gown
handwash
recommend
droplet
precaugoggl
cotton
surgic
gown
patient
treat
potent
tion
staff
member
report
use
four
measur
antibiot
usual
form
combin
cephalosporin
infect
contrast
infect
staff
member
omit
macrolid
event
allergi
antibiot
least
one
measur
p
author
observ
levofloxacin
patient
improv
clinic
radiolog
surgic
high
effici
mask
mask
proar
unlik
sar
move
ward
nt
tectiv
infect
wherea
paper
mask
significantrequir
level
intens
care
andor
isol
would
ly
reduc
transmiss
mask
easili
wet
saliva
requir
patient
sar
observ
recommend
precaut
droplet
day
discharg
event
confirm
suspect
order
prepar
recurr
sar
need
sar
patient
divert
appropri
ward
earli
implement
control
measur
us
cdc
reminim
exposur
fellow
patient
singleroom
accomleas
clinic
guidelin
identif
evalu
modat
could
provid
possibl
sarscov
diseas
among
patient
present
communityacquir
ill
key
principl
upon
control
conclus
measur
base
taken
consider
fact
year
vast
major
patient
sarscov
diseas
new
viru
caus
sar
difficult
predict
clear
histori
exposur
either
sar
patient
eventu
signific
infect
howev
reset
srscov
transmiss
occur
ie
hospit
emerg
sporad
case
china
caus
great
concern
develop
pneumonia
recommend
evalu
futur
impact
enorm
econom
polit
patient
communityacquir
respiratori
ill
deimpact
affect
area
world
although
import
velop
two
primari
circumst
firstli
absenc
progress
made
concern
etiolog
epidemiolog
sarscov
transmiss
anywher
world
secondli
prevent
viru
mani
import
question
remain
transmiss
document
releas
prior
without
answer
question
eventu
provinc
china
close
contact
ill
person
outcom
sar
remain
unclear
histori
recent
travel
area
day
onset
symptom
patient
identifi
appropri
isola
